Maki Otsuka Selected Research

Cladribine

8/2007

[Remarkable response to cladribine in the treatment for hairy B cell lymphoproliferative disorder].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Maki Otsuka Research Topics

Disease

4	Lymphoma (Lymphomas) 12/2020 - 03/2009
3	Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated) 12/2016 - 01/2007
3	Neoplasms (Cancer) 12/2016 - 03/2009
3	Atherosclerosis 04/2015 - 09/2009
2	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 03/2020 - 04/2018
2	Hemorrhage 03/2020 - 04/2018
2	Multiple Myeloma 01/2017 - 05/2016
2	Disease Progression 12/2016 - 05/2016
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2015 - 01/2007
2	Atrial Fibrillation 04/2012 - 02/2009
2	Insulin Resistance 12/2011 - 09/2009
2	Hypertension (High Blood Pressure) 12/2011 - 10/2010
1	COVID-19 01/2022
1	Pneumonia (Pneumonitis) 01/2022
1	Hypoxia (Hypoxemia) 01/2022
1	T-Cell Lymphoma (Lymphoma, T Cell) 01/2021
1	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 01/2021
1	Cardiovascular Diseases (Cardiovascular Disease) 04/2015
1	Chromosome Aberrations (Chromosome Abnormalities) 01/2015
1	Obesity 04/2011
1	Sepsis (Septicemia) 12/2009
1	Critical Illness (Critically Ill) 12/2009
1	Carotid Artery Diseases 06/2008
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 10/2007
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 08/2007

Drug/Important Bio-Agent (IBA)

4	Dexamethasone (Maxidex)FDA LinkGeneric 03/2020 - 05/2016
3	Lenalidomide (CC 5013)FDA Link 01/2017 - 05/2016
2	Inosine Triphosphate (ITP)IBA 03/2020 - 04/2018
2	HDL CholesterolIBA 01/2011 - 09/2009
2	Antihypertensive Agents (Antihypertensives)IBA 10/2010 - 02/2009
1	AnticoagulantsIBA 01/2022
1	Antiviral Agents (Antivirals)IBA 01/2022
1	Indicators and Reagents (Reagents)IBA 12/2020
1	Prednisolone (Predate)FDA LinkGeneric 03/2020
1	mogamulizumabIBA 01/2018
1	Melphalan (Alkeran)FDA LinkGeneric 05/2016
1	Prednisone (Sone)FDA LinkGeneric 05/2016
1	Thalidomide (Thalomid)FDA Link 05/2016
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 04/2015
1	Alkylating AgentsIBA 01/2015
1	Podophyllotoxin (Condylox)FDA LinkGeneric 01/2015
1	AnthracyclinesIBA 01/2015
1	Troponin T (Troponin T1)IBA 04/2012
1	CholesterolIBA 01/2012
1	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 01/2012
1	AldosteroneIBA 12/2011
1	GhrelinIBA 04/2011
1	oxidized low density lipoproteinIBA 01/2011
1	LDL CholesterolIBA 01/2011
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2011
1	Endothelin-1 (Endothelin 1)IBA 10/2010
1	Proteins (Proteins, Gene)FDA Link 12/2009
1	HMGB1 Protein (HMG1)IBA 12/2009
1	Biomarkers (Surrogate Marker)IBA 09/2009
1	AcidsIBA 09/2009
1	Fibrinogen (Factor I)FDA Link 09/2009
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2009
1	Triglycerides (Triacylglycerol)IBA 09/2009
1	CreatinineIBA 09/2009
1	C-Reactive ProteinIBA 09/2009
1	Insulin (Novolin)FDA Link 09/2009
1	AntigensIBA 03/2009
1	N,N-dimethylarginine (asymmetric dimethylarginine)IBA 06/2008
1	Cladribine FDA LinkGeneric 08/2007

Therapy/Procedure

6	Therapeutics 01/2022 - 01/2015
3	Drug Therapy (Chemotherapy) 12/2016 - 01/2007
2	Hematopoietic Stem Cell Transplantation 01/2021 - 01/2017
1	Combination Drug Therapy (Combination Chemotherapy) 01/2015
1	Aftercare (After-Treatment) 10/2007